Pharmacists To Face Music If Found Illegally Diverting Codeine-Based Cough Syrups

Mumbai : The pharmacists will face the music if they are selling Codeine-based cough syrups without valid prescription as the Narcotics Control Bureau (NCB) is probing its trafficking through children and terminally ill persons. Codeine is also an opiate and used in reducing pain. The medicine containing it can be bought against a prescription. NCB sources stated that such syrups are common among drug abusers as a bottle is available for Rs 150. “We will verify them if the investigation leads towards that angle,” said a high-ranking officer.

The agency which recently arrested peddlers revealed certain disturbing facts. The investigations have revealed that the cough syrup is abused by children in slums and terminally ill persons. The peddlers also encourage them to further peddle the drugs in exchange for more bottles of the syrup, NCB sources said.The NCB probe has revealed that drugs are being diverted for illicit sale which are later abused by slum children in pockets such as Govandi, Kurla and Dharavi. The source of such diversion can be traced to Himachal Pradesh, the probe revealed.

The agency stated that over-the-counter sale in medical shops without prescription can be dangerous and further fuel the habit among drug abusers. NCB stated that the said syrup “WELCYREX” contains codeine phosphate which is the reason it is being abused. The agency has now launched a full-fledged probe to detect bulk supply chains or source of such codeine-based cough syrups.

As per the Narcotic Drugs and Psychotropic Substances Act, 1985 (NDPS) provisions, codeine phosphate commercial quantity is 1000 gram. Illegal diversion of neuro-psychotropic drugs is a punishable offence under NDPS Act. Earlier this month, action was initiated after NCB intercepted two persons namely Siraj Ahmed and Mohamed Saddam from Dharavi, and seized 23.9 kgs of Codeine based cough syrup.

  • Related Posts

    Annovis Bio receives US patent covering new crystalline form of buntanetap

    Annovis Bio, Inc. (Annovis), a phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), announced that…

    Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

    The enforcement wing of Karnataka’s Food Safety and Drugs Control Department has seized medical devices and consumables worth ₹13.79 lakh from two establishments in Bengaluru’s Cottonpet area for alleged violations…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Annovis Bio receives US patent covering new crystalline form of buntanetap

    Annovis Bio receives US patent covering new crystalline form of buntanetap

    Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

    Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

    Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

    Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels